BeyondSpring Announces Leadership Transition to Deliver Focused Execution on Its Confirmatory DUBLIN-4 Program and Long-Term Value
BeyondSpring Presents the Latest Update of a Phase 2 Study Demonstrating Durable Clinical Benefit of Pembrolizumab Plus Plinabulin/Docetaxel in Metastatic NSCLC After Progression on First-Line Immune Checkpoint Inhibitor Therapy at ASCO 2026
BeyondSpring Reports Compelling New Data: Plinabulin Advances Both the Anticancer Efficacy and Safety of ADC Drugs
LaFleur Minerals Engages Maximus Strategic Consulting Inc. for Investor Relations and Marketing Services
West High Yield Resources Receives BC Ministry of Transportation and Transit Access Permit for Record Ridge Magnesium Project and Announces Second Tranche Closing of Private Placement
